CME Webinar: Pediatric Collaborative Call—Addressing Health Disparities: Impact on Maternal and Pediatric Health

Oct. 2022Education/Webinars
"Please join us for a live, CME-accredited webinar Wednesday, Nov. 16, from noon to 1 p.m. The presentation will include an overview of how to address health disparities, including:

  • Understanding the difference between health equity and health equality.
  • Recognizing key maternal and pediatric health disparity trends.
  • Defining social determinants of health.
  • Understanding the role providers, health plans, health systems, and communities have in recognizing health disparities and resources to improve those outcomes.


Presenters:
  • Johanna Vidal-Phelan, MD, MBA, FAAP, Chief Medical Officer – Quality Department UPMC Insurance Services Division; Clinical Assistant Professor of Pediatrics University of Pittsburgh School of Medicine
  • Katie Domalakes, MSW/LSW, Senior Director Clinical Affairs and Program Development, UPMC for You and UPMC for Kids, UPMC Health Plan
  • Elana Glick, MPH, CPH, MCHES, NBC-HWC, Director, Clinical Programs Health Management, UPMC Health Plan
  • Debra Zeh, RN, BSN, Senior Director of Quality Provider Performance, UPMC Health Plan


Register now. This webinar will be recorded.

You may earn continuing medical education (CME) credits for attending this webinar.*

*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility. "

Recent Announcements

Medicaid Renewal

Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.
Aug. 2026Important Notices

Provider Directory Updates and Required Attestation

As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).
Aug. 2026Important Notices

Voluntary nationwide recall: Tyenne (Fresenius – August 2026)

Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.
Aug. 2026Pharmacy Updates